Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MYCAPSSA® safely and effectively. See full prescribing information for MYCAPSSA. MYCAPSSA (octreotide) delayed-release capsules, for oral use Initial U.S. Approval: 1988
Medication labelWhy this: Advisory · dailymed-prescription
MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide.
- generic_name
- octreotide
- product_names
- Octreotide
- ndc
- 69880-120, 69880-120-28
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en